Lately, there’s been a lot of talk about immunotherapy, which has transformed treatment for patients with some kinds of cancer. So far, patients with NETs and NECs have largely been excluded from these developments. But there’s hope that the benefits of immunotherapy could one day extend to NENs. In this episode of NETWise, we’re going to explore current research into immunotherapy, and what it might mean for patients.

Daniel M. Halperin, MD, Associate Professor and Vice Chair for Clinical Affairs in the Department of Hematology and Medical Oncology at Emory University

Eleonora Pelle, MD, Post-Doctoral Researcher, Moffitt Cancer Center

Dr. Mauro Cives, MD, Senior Assistant Professor of Medical Oncology in the Department of Interdisciplinary Medicine of the University of Bari

A special thank you to NETRF board member and NET caregiver, Laurie Littlepage, PhD, for sharing her story.

Click here to download a transcript of this episode.